533 related articles for article (PubMed ID: 15713798)
1. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
[TBL] [Abstract][Full Text] [Related]
2. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
3. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
4. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.
Tangye SG; Lazetic S; Woollatt E; Sutherland GR; Lanier LL; Phillips JH
J Immunol; 1999 Jun; 162(12):6981-5. PubMed ID: 10358138
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
Morra M; Lu J; Poy F; Martin M; Sayos J; Calpe S; Gullo C; Howie D; Rietdijk S; Thompson A; Coyle AJ; Denny C; Yaffe MB; Engel P; Eck MJ; Terhorst C
EMBO J; 2001 Nov; 20(21):5840-52. PubMed ID: 11689425
[TBL] [Abstract][Full Text] [Related]
8. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
9. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.
Howie D; Simarro M; Sayos J; Guirado M; Sancho J; Terhorst C
Blood; 2002 Feb; 99(3):957-65. PubMed ID: 11806999
[TBL] [Abstract][Full Text] [Related]
11. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
12. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity and molecular competition in SLAM family receptor signalling.
Wilson TJ; Garner LI; Metcalfe C; King E; Margraf S; Brown MH
PLoS One; 2014; 9(3):e92184. PubMed ID: 24642916
[TBL] [Abstract][Full Text] [Related]
14. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
15. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
16. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
17. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
Sayós J; Martínez-Barriocanal A; Kitzig F; Bellón T; López-Botet M
Biochem Biophys Res Commun; 2004 Nov; 324(2):640-7. PubMed ID: 15474475
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NKp30- and 2B4-mediated NK cell activation by evolutionary different human and bovine CEACAM1 receptors.
Merkt W; Urlaub D; Meinke S; Kammerer R; Watzl C
Eur J Immunol; 2015 Jul; 45(7):2134-42. PubMed ID: 25824372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]